发明授权
US07820687B2 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4
有权
抑制由VLA-4介导的白细胞粘附的嘧啶基磺酰胺化合物
- 专利标题： Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4
- 专利标题（中）： 抑制由VLA-4介导的白细胞粘附的嘧啶基磺酰胺化合物
-
申请号： US12505383申请日： 2009-07-17
-
公开(公告)号： US07820687B2公开(公告)日： 2010-10-26
- 发明人: Jenifer Smith , Chris Semko , Ying-Zi Xu , Andrei W. Konradi
- 申请人： Jenifer Smith , Chris Semko , Ying-Zi Xu , Andrei W. Konradi
- 申请人地址： US CA South San Francisco
- 专利权人： Elan Pharmaceuticals, Inc.
- 当前专利权人： Elan Pharmaceuticals, Inc.
- 当前专利权人地址： US CA South San Francisco
- 代理机构： Swiss Tanner, P.C.
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; A61P1/06 ; A61P11/06 ; A61P19/02 ; A61P25/14 ; A61P35/04 ; A61P37/06 ; C07D239/50 ; C07D403/12
摘要：
Disclosed are compounds, which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a human or animal subject such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, Crohn's disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
公开/授权文献
信息查询
IPC分类:
